跳至主要内容
临床试验/CTRI/2014/06/004670
CTRI/2014/06/004670招募中未知

A Randomized Controlled Trial to Investigate the Effects of Vitamin D supplementation on maternal and new-born babyâ??s vitamin D status in Asian-Indian Subjects. - VIDIMA

Indian Council of Medical Research ICMR0 个研究点目标入组 368 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
368

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pregnant women between 12-16 weeks of gestation.
  • Age between 18 to 35 years.
  • Subjects agrees for delivery conducted at the AIIMS

排除标准

  • Subjects will be excluded from the study if they
  • Have more than one gestation in current pregnancy
  • Complicated medical or obstetric history that may increase the risk of preterm birth or labor/ delivery complications, based on self-report or clinical assessment by obstetrician (cardiovascular disease, more than three abortions ,hypertension, preeclampsia or Rh isoimmunization)
  • Prior history of delivery of an infant with chromosomal abnormalities or IUGR in previous pregnancy
  • Presence of any diagnosed systemic disease known to affect vitamin D status such as malabsorption states, liver and renal disorders, primary and tertiary hyperparathyroidism.
  • Have features suggestive of osteomalacia or severe VDD.
  • Pre-existing hypertension
  • Already diagnosed with diabetes (type 1 or 2)
  • Are taking or had taken vitamin D supplementation in last two months in doses exceeding 600 IU/day.
  • Are using medications known to interact with vitamin D metabolism (steroids,thiazide diuretics, phenytoin, phenobarbitone and antitubercular drugs).
  • Have known hypersensitivity to Vitamin D
  • preparations.
  • Have participated in any other investigational drug study in previous three months.
  • Have past history of bariatric surgery.
  • Are using Ultra-Violet (UV) radiations as a part of medical therapy.
  • Are diagnosed with albinism or have other condition associated with decreased skin pigmentation.
  • Have any medical condition that in the judgment of the investigator would jeopardize the subjectâ??s safety or evaluation of study drug for efficacy or safety .
  • Additional exclusion criteria will be applied after biochemical screening:
  • Having gestational diabetes between 12-16 weeks of pregnancy.
  • Have serum calcium more than 1 mg/dL above the upper limit of normal for age.
  • Have serum S.25(OH)D level more than 100 ng/mL.

研究者

发起方
Indian Council of Medical Research ICMR

相似试验

Vitamin D supplementation in Pregnancy | 临床试验